Buldak spicy noodles are back on shelves in Denmark after the food authorities there canceled part of their recall decision concerning the famous Korean instant noodles product, originally issued due to their extreme spiciness and consequent health risks.
The Danish Veterinary and Food Administration announced, Monday, that two of the three products that had been recalled were not harmful to health, based on updated risk assessments.
Based on the new analysis results and the DTU Food Institute's updated risk assessment, the administration concludes that two of the products, Samyang Buldak 2x Spicy Hot Chicken and Samyang Buldak Hot Chicken Stew, do not contain capsaicin levels as high as those reported by the distributors in the marketing.
Therefore, the two products are no longer considered harmful to health and can be marketed again in Danish stores.
The administration noted that the poison hotline had received reports of 14 cases following the consumption of 3x Spicy Hot Chicken noodles, with symptoms including stomach pain and vomiting.
Announcing the recall, the authorities expressed concerns that Buldak noodles, often consumed by children and young people as part of spicy noodle challenges, could lead to acute poisoning.
However, the Danish authorities maintained the recall decision on Buldak 3x Spicy Hot Chicken, the spiciest product in the Buldak line, stating that it is still believed to be harmful to health.
They cited the high capsaicin level as posing a risk to consumers developing acute poisoning upon consumption.
The U-turn decision comes about a month after the Danish food authorities pulled the three instant noodle products from the shelves on June 12, citing a risk of acute poisoning due to the products' high capsaicin content.
The Danish food administration found that the levels of total capsaicin in a single pack of the three types of Buldak noodles are similar to or higher than those in a Paqui Carolina Reaper chip, an extremely spicy tortilla chip that led to many hospitalizations in Germany.